Stay updated on Deucravacitinib Safety Efficacy in UC Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Safety Efficacy in UC Clinical Trial page.

Latest updates to the Deucravacitinib Safety Efficacy in UC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page history now shows Revision: v3.3.3, and HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision history now shows the addition of v3.3.2 and the removal of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedThe funding status notice at the top of the ClinicalTrials.gov page was removed. This is a non-substantive site banner update and does not alter trial details or history.SummaryDifference0.3%

- Check63 days agoChange DetectedThe version history includes multiple updates to the Study Status and Locations, reflecting changes to site locations and contact information.SummaryDifference0.0%

- Check91 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference9%

- Check99 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Deucravacitinib Safety Efficacy in UC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety Efficacy in UC Clinical Trial page.